Tacrolimus and steroids versus ciclosporin microemulsion, steroids, and azathioprine in children undergoing liver transplantation: Randomised European multicentre trial

Lancet

Volumn 364, Issue 9439, 2004, Pages 1054-1061

  Kelly, Deirdre ^a   Jara, Paloma ^b   Rodeck, Burkhard ^c   Lykavieris, Panayotis ^d   Burdelski, Martin ^e   Becker, Michael ^f   Gridelli, Bruno ^g   Boillot, Olivier ^h   Manzanares, Javier ⁱ   Reding, Raymond ^j  

^a BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b HOSPITAL INFANTIL LA PAZ   (Spain)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d BICÊTRE HOSPITAL   (France)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g OSPEDALI RIUNITI   (Italy)

^h EDOUARD HERRIOT HOSPITAL   (France)

ⁱ Hospital Materno Infantil Doce de Octubre   (Spain)

^j CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; GANCICLOVIR; METHYLPREDNISOLONE; PREDNISOLONE; STEROID; TACROLIMUS;

ACIDOSIS; ACUTE KIDNEY FAILURE; ADOLESCENT; AGITATION; ANEMIA; ANXIETY; ARTICLE; ASCITES; BODY WEIGHT; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVULSION; DATA ANALYSIS; DIABETES MELLITUS; DIARRHEA; FEMALE; FEVER; GASTROINTESTINAL HEMORRHAGE; GINGIVA HYPERPLASIA; GINGIVA HYPERTROPHY; GRAFT REJECTION; GRAFT SURVIVAL; HIRSUTISM; HUMAN; HYPERTENSION; HYPOMAGNESEMIA; KAPLAN MEIER METHOD; KIDNEY DISEASE; LIVER TRANSPLANTATION; LYMPHADENOPATHY; LYMPHOPROLIFERATIVE DISEASE; MALE; MICROEMULSION; MULTICENTER STUDY; NEUROLOGIC DISEASE; OLIGURIA; PHARYNGITIS; PLEURA EFFUSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SURVIVAL; TREMOR;

EID: 4544380236     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)17060-8     Document Type: Article

References (25)

1. European FK506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet. 344:1994;423-428
2. The US Multicentre FK506 Liver Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. New Engl J Med. 331:1994;1110-1115
3. O'Grady JG, Burroughs A, Hardy P, Elbourne D, Truesdale A. Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trial. Lancet. 360:2002;1119-1125
4. Reding R. Tacrolimus in paediatric liver transplantation. Pediatr Transplant. 6:2002;447-451
5. Cao S, Cox KL, Berquist W, et al. Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus. Pediatr Transplant. 3:1999;22-26
6. McDiarmid SV, Busuttil RW, Ascher NL, et al. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Transplantation. 59:1995;530-536
7. Cox KL, Lawrence-Miyasaki LS, Garcia-Kennedy R, Lennette ET, Martinez OM, Krams SM. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK506 after liver transplantation. Transplantation. 59:1995;524-529
8. Jain A, Mazariegos G, Kashyap R, et al. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation. Transplantation. 70:2000;617-625
9. Wallemacq PE, Furlan V, Moller A, et al. Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients. Eur J Drug Metab Pharmacokinet. 23:1998;367-370
10. McDiarmid SV, Colonna JO, Shaked A, Vargas J, Ament ME, Busuttil RW. Differences in oral FK506 dose requirements between adult and pediatric liver transplant patients. Transplantation. 55:1993;1328-1332
11. Nakata Y, Yoshibayashi M, Yonemura T, et al. Tacrolimus and myocardial hypertrophy. Transplantation. 69:2000;1960-1962
12. Cox KL, Freese DK. Tacrolimus (FK506): the pros and cons of its use as an immunosuppressant in pediatric liver transplantation. Clin Invest Med. 19:1996;389-392
13. Atkison P, Joubert G, Barron A, et al. Hypertrophic cardiomyopathy associated with tacrolimus in paediatric transplant patients. Lancet. 345:1995;894-896
14. Smets F, Sokal EM. Epstein-Barr virus-related lymphoproliferation in children after liver transplant: role of immunity, diagnosis, and management. Pediatr Transplant. 6:2002;280-287
15. Kogan-Liberman D, Burroughs M, Emre S, Moscona A, Shneider BL. The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience. J Pediatr Gastroenterol Nutr. 33:2001;445-449
16. Rowe DT, Webber S, Schauer EM, Reyes J, Green M. Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease. Transplant Infect Dis. 3:2001;79-87
17. Spada M, Guizzetti M, Petz W, et al. Circulating Epstein-Barr virus DNA to monitor lymphoproliferative disease following pediatric liver transplantation. Transplant Int. 13:(suppl 1):2000;399-401
18. Krieger NR, Martinez OM, Krams SM, Cox K, So S, Esquivel CO. Significance of detecting Epstein-Barr-specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients. Liver Transpl. 6:2000;62-66
19. Moore R, Hernandez D, Valantine H. Calcineurin inhibitors and post-transplant hyperlipidaemias. Drug Saf. 24:2001;755-766
20. Johnston SD, Morris JK, Cramb R, Gunson BK, Neuberger J. Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation. 73:2002;901-906
21. Loss M, Winkler M, Schneider A, Oldhafer K, Manns MP, Pichlmayr R. Glucose and lipid metabolism in liver transplant patients under long-term tacrolimus (FK 506) monotherapy. Transplant Proc. 28:1996;1006-1007
22. Loss M, Winkler M, Schneider A, et al. Influence of long-term cyclosporine or FK 506 therapy on glucose and lipid metabolism in stable liver graft recipients. Transplant Proc. 27:1995;1136-1139
23. Mühlbacher F, for the European Liver Transplantation vs Cyclosporin Microemulsion Study Group. Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study. Transplant Proc 2001; 33: 1339-40.
24. Jain A, Mazariegos G, Pokharna R, et al. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Transplantaion. 75:2003;1020-1025
25. Fridell JA, Jain A, Reyes J, et al. Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus. Transplantation. 74:2002;1721-1724